Dubai, UAE – February 26, 2025
The Dubai Stem Cell Congress (DSCC 2025) officially opened today at The Ritz-Carlton, DIFC, welcoming over 500 delegates, including leading scientists, medical professionals, and industry experts. Organized by First Stem Cell and Genomics Laboratory (FSG) and supported by the Dubai Health Authority (DHA), the event highlights the latest advancements in stem cell and regenerative medicine.
The opening ceremony began with a welcome note, followed by the national anthem and an introductory video showcasing First Stem Cell and Genomics Laboratory’s contributions to stem cell research in the UAE.
Dr. Fatma Al Hashimi, Chairperson of DSCC and Director of First Stem Cell and Genomics Laboratory, delivered the opening speech, emphasizing the importance of advancing stem cell research, clinical applications, and public awareness. She highlighted FDA-approved stem cell therapies for blood cancers, thalassemia, and autoimmune diseases.
Hassan Al Hashemi, Vice President of the Chamber of Commerce Executive Office, addressed the audience, focusing on the role of innovation and collaboration in strengthening Dubai’s position as a hub for biotechnology and regenerative medicine.
A key moment of the ceremony was the awarding of GMP (Good Manufacturing Practice) Certification to First Stem Cell and Genomics Laboratory, making it the first GMP-certified stem cell lab in the UAE. This certification ensures the highest safety and quality standards in stem cell processing and therapy, marking a major milestone for the industry.
The event concluded with an award ceremony and a special performance, setting the stage for two days of insightful discussions, scientific presentations, and workshops focused on the future of stem cell and gene therapy.
